Home / Pharmaceuticals / Urinary Tract Infection (UTI) Treatment Market By Drug Type (Penicillin, Quinolones, Cephalosporin, Sulphonamides, Tetracycline, Other) - Growth, Future Prospects, and Competitive Analysis, 2017 - 2025

Urinary Tract Infection (UTI) Treatment Market By Drug Type (Penicillin, Quinolones, Cephalosporin, Sulphonamides, Tetracycline, Other) - Growth, Future Prospects, and Competitive Analysis, 2017 - 2025

Published: Oct 2017 | Report Code: 58749-10-17

Urinary tract infection (UTI) is a most common type of infection, it involve infection to the kidneys, ureters, bladder, or urethra. UTI treatment market is rapidly growing due to factors such as growing prevalence of UTI, significant unmet needs, rising number of drug resistant bacteria due to excessive use of antibiotics.

The report titled “Urinary Tract Infection (UTI) Treatment Market - Growth, Future Prospects and Competitive Analysis, 2017–2025” offers strategic insights into the overall UTI treatment market along with the market size and estimates for the duration 2015 to 2025. The research study covers in-depth analysis of market segments based on drug class (penicillin, quinolones, cephalosporin, sulphonamides, tetracycline and other) and different geographical regions. Geographically, the global UTI treatment market is studied for the following regional markets:

  • North America
    • U.S.
    • Canada
  • Europe
    • U.K.
    • Germany
    • Rest of Europe
  • Asia-Pacific
    • China
    • Japan
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of LATAM
  • Middle East and Africa
    • GCC
    • Rest of MEA

Market size and forecast for these regional and country level markets are presented in this study for the period 2015-2025. Market growth rates for the forecast period 2017-2025 are also included in this report, considering 2016 as the base year.

Along with quantitative information, qualitative information sets and assessment tools are provided in this study for better analysis of the overall market scenario and future prospects. Information such as market inclination insights and drivers, challenges and opportunities assists the readers for understanding the ongoing trends in the global UTI treatment market. Tools such as market positioning of key players and attractive investment proposition provide the readers with insights on the competitive scenario of the global UTI treatment market. This report concludes with company profiles section that highlights major information about the key players engaged in global UTI treatment market. In-depth competitive environment analysis and historical years (2015) market size data are also provided in the report.      

Thus, the research study provides a holistic view of the global UTI treatment market, offering market size and estimates for the period from 2015 to 2025, keeping in mind the above-mentioned factors.

Urinary Tract Infection (UTI) Treatment Market

Chapter 1 Preface
1.1 Report Description
1.1.1 Purpose of the Report
1.1.2 Target Audience
1.1.3 USP and Key Offerings
1.2 Research Scope
1.3 Research Methodology
1.3.1 Phase I – Secondary Research
1.3.2 Phase II – Primary Research
1.3.3 Phase III – Expert Panel Review
1.3.4 Assumptions

Chapter 2 Executive Summary
2.1 Global Urinary Tract Infection (UTI) Treatment Market Snapshot
2.2 Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class
2.3 Global Urinary Tract Infection (UTI) Treatment Market Share, by Geography, 2016 (Value %)

Chapter 3 Urinary Tract Infection (UTI) Treatment Market Analysis
3.1 Global Urinary Tract Infection (UTI) Treatment Market Overview
3.2 Market Dynamics
3.2.1 Market Drivers
3.2.2 Challenges
3.2.3 Opportunities
3.3 Attractive Investment Proposition
3.4 Competitive Landscape of Key Players in Urinary Tract Infection (UTI) Treatment Market
3.5 Top 3 Countries

Chapter 4 Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class
4.1 Overview
4.2 Attractive Investment Proposition: Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class
4.3 Penicillin
4.4 Quinolones
4.5 Cephalosporin
4.6 Sulphonamides
4.7 Tetracycline
4.8 Other

Chapter 5 Global Urinary Tract Infection (UTI) Treatment Market, By Geography
5.1 Preface
5.2 North America (U.S. & Canada)
5.2.1 North America Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015- 2025 (US$)
5.2.2 North America Urinary Tract Infection (UTI) Treatment Market, by Country, 2015- 2025 (US$)
5.3 Europe (U.K., Germany & Rest of Europe)
5.3.1 Europe Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015- 2025 (US$)
5.3.2 Europe Urinary Tract Infection (UTI) Treatment Market, by Country, 2015- 2025 (US$)
5.4 Asia Pacific (China, Japan and Rest of APAC)
5.4.1 Asia Pacific Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015- 2025 (US$)
5.4.1 Asia Pacific Urinary Tract Infection (UTI) Treatment Market, by Country, 2015- 2025 (US$)
5.5 Latin America (Brazil, Mexico and Rest of LATAM)
5.5.1 Latin America Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015- 2025 (US$)
5.5.2 Latin America Urinary Tract Infection (UTI) Treatment Market, by Country, 2015- 2025 (US$)
5.6 Middle East and Africa (GCC and Rest of MEA)
5.6.1 Middle East and Africa Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015- 2025 (US$)
5.6.2 Middle East and Africa Urinary Tract Infection (UTI) Treatment Market, by Country, 2015- 2025 (US$)

Chapter 6 Company Profiles
6.1 AstraZeneca plc.
6.2 Bayer AG
6.3 Cubist Pharmaceuticals
6.4 F. Hoffmann–La Roche Ltd.
6.5 GlaxoSmithKline Pharmaceuticals Ltd.
6.6 Johnson & Johnson
6.7 MerLion Pharmaceuticals
6.8 Osel Inc.
6.9 Pfizer Inc.
6.10 Rempex Pharmaceuticals

List of Tables

TABLE 1 Market Positioning of Key Players in Global Urinary Tract Infection (UTI) Treatment Market
TABLE 2 Top 3 Countries in Global Urinary Tract Infection (UTI) Treatment Market
TABLE 3 Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015 – 2025 (US$ Bn)
TABLE 4 Global Urinary Tract Infection (UTI) Treatment Market, by Geography, 2015 – 2025 (US$ Bn)
TABLE 5 North America Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 6 North America Urinary Tract Infection (UTI) Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 7 Europe Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 8 Europe Urinary Tract Infection (UTI) Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 9 Asia Pacific Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 10 Asia Pacific Urinary Tract Infection (UTI) Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 11 Latin America Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 12 Latin America Urinary Tract Infection (UTI) Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 13 Middle East and Africa Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2015-2025 (US$ Bn)
TABLE 14 Middle East and Africa Urinary Tract Infection (UTI) Treatment Market, by Country, 2015 – 2025 (US$ Bn)
TABLE 15 AstraZeneca plc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 16 Bayer AG: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 17 Cubist Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 18 F. Hoffmann–La Roche Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 19 GlaxoSmithKline Pharmaceuticals Ltd.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 20 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 21 MerLion Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 22 Osel Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 23 Pfizer Inc.: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage)
TABLE 24 Rempex Pharmaceuticals: Company Snapshot (Business Description; Financial Information; Product Position/Portfolio; News Coverage) 

List of Figures

FIG. 1 Urinary Tract Infection (UTI) Treatment Market: Research Methodology
FIG. 2 Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2016 (US$ Bn)
FIG. 3 Global Urinary Tract Infection (UTI) Treatment Market Share, by Geography, 2016 (Value %)
FIG. 4 Attractive Investment Proposition: Global Urinary Tract Infection (UTI) Treatment Market, by Geography, 2016
FIG. 5 Attractive Investment Proposition: Global Urinary Tract Infection (UTI) Treatment Market, by Drug Class, 2016
FIG. 6 Global Penicillin Market, 2015 – 2025 (US$ Bn)
FIG. 7 Global Quinolones Market, 2015 – 2025 (US$ Bn)
FIG. 8 Global Cephalosporin Market, 2015 – 2025 (US$ Bn)
FIG. 9 Global Sulphonamides Market, 2015 – 2025 (US$ Bn)
FIG. 10 Global Tetracycline Market, 2015 – 2025 (US$ Bn)
FIG. 11 Global Other Drugs in UTI treatment Market, 2015 – 2025 (US$ Bn)

Based on drug class, the global urinary tract infection (UTI) treatment market is segmented as follows:

  • Penicillin
  • Quinolones
  • Cephalosporin
  • Sulphonamides
  • Tetracycline
  • Other

Urinary tract infection (UTI) is a most common type of infection, it involve infection to the kidneys, ureters, bladder, or urethra. Some factors such as growing prevalence of UTI, rising incidence of risk factors such as diabetes and kidney stone, early diagnosis of UTI and changing lifestyle pattern are prime factors that are driving the growth of UTI treatment market globally. Drug resistance due to excessive use of antibiotic and increasing number of drug resistant bacteria are another factors that would assist market growth during forecast period. For the purpose the study, UTI treatment market is segmented on the basis of drug class such as penicillin, quinolones, cephalosporin, sulphonamides, tetracycline and others. It is observed that, in the base year 2016, demand for the quinolones was highest in market as these are preferred as first line treatment option due to higher bioavailability with lesser side effects. Physicians generally prescribe a quinolone medicine if there is no existing other treatment options remaining for the treatment of complicated UTI or kidney infection.

Urinary Tract Infection (UTI) Treatment Market

For the purpose of this study, the global urinary tract infection (UTI) treatment market is categorized into:

  • North America
  • Europe
  • Asia Pacific
  • Latin America (LATAM)
  • Middle East and Africa (MEA)

Urinary Tract Infection (UTI) Treatment Market

Urinary tract infection (UTI) is one of the most common type of infections, occurring in any part of urinary tract such as ureters, kidneys, urethra, or bladder. According to world health organization (WHO), approximately 50% of women report having a UTI at some point in their lives. Among the considered geographical segment, North America was major revenue contributor in 2016. Early diagnosis, higher treatment awareness, swift adoption of novel medications and better reimbursement policies in healthcare systems are the prime contributors for the dominance of North America. Higher Expenditure on healthcare in the United States as compared to other nations is another factor contributing the market growth in North America. According to Urology Foundation of America, 1 in 5 women will develop UTIs in their lifetime in America. However, due to rising healthcare awareness among general patient population, growing number of investment and partnering of key player with local manufacturers are expected to assist the UTI treatment market growth in Asia-Pacific.

Choose License Type
Connect With Us
+1-800-361-8290
24/7 Research Support

Credence Webinars

Join Credence analysts to explore the latest IT Trends

view upcoming webinars

Our Clients